Twist Bioscience Corporation TWST EMEA — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's emea — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's EMEA — revenue?
- Twist Bioscience Corporation (TWST) reported EMEA — revenue of $37.35M in Q1 2026.
- How has Twist Bioscience Corporation's EMEA — revenue changed year-over-year?
- Twist Bioscience Corporation's EMEA — revenue increased by 21.9% year-over-year, from $30.64M to $37.35M.
- What is the long-term trend for Twist Bioscience Corporation's EMEA — revenue?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's EMEA — revenue has grown at a 29.5% compound annual growth rate (CAGR), from $44.12M to $124.24M.
- What does EMEA — revenue mean?
- This metric represents the total net sales generated from customers located within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and adoption rate of its synthetic DNA products and services within these specific international markets. Tracking this revenue stream provides insight into the company's global expansion strategy and the relative demand for its semiconductor-based DNA synthesis platform outside of its primary domestic market.